Family Medicine Doctors in Spring Grove, MN Accepting Medicare
3 Family Medicine doctors found. Showing 1 - 3
 Robert A Breitenbach, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 123 5th Ave Se, Spring Grove, MN 55974 Phone: 507-498-3302 |
Dr. Gregory N Tjossem, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 123 5th Ave Se, Spring Grove, MN 55974 Phone: 608-782-7300 |
Glenn P Mccarty, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 125 5th Ave Se, Spring Grove, MN 55974 Phone: 507-498-3302 |
News Archive
Caring for Alzheimer's patients proves costly
Newsday reports that the high cost of caring for Alzheimer's patients "can easily deplete even the deepest bank account. Because the disease lasts so long - anywhere from two to 20 years, depending on the stage at diagnosis - and because the type of care needed often falls beyond the scope of government health care programs, families find themselves scrambling to find the money needed to maintain care for their loved one."
IRIN examines antibiotic resistance, efforts to discover new drugs
IRIN examines a global increase in resistance to antibiotics, writing, "Almost one in every five deaths worldwide occurs as a result of infection, but many bacterial illnesses will become incurable as the efficacy of current antibiotic drugs wanes, according to the World Health Organization (WHO)."
Groundbreaking research aims to provide more effective treatment for women with cervical cancer
UNIVERSITY of Huddersfield researcher Dr Tsitsi Chituku is taking part in a project that seeks to learn more about the genetic factors that make some women more susceptible to cervical cancer. It was a recent visit to Africa, to carry out a health screening project involving hundreds of women, which helped to shape the emphasis of her research.
Article describes immune-related adverse events with newly approved melanoma drug
An internationally recognized melanoma researcher at Moffitt Cancer Center and colleagues at the University of Kiel in Germany, including Axel Hauschild, M.D. and Katharina C. K-hler, M.D., have published an article in the current issue of The Journal of Clinical Oncology that describes immune-related adverse events for patients receiving either tremelimumab or ipilimumab, the latter a drug approved last year by the U.S. Food and Drug Administration for treating metastatic melanoma and other cancers.
› Verified 3 days ago